.png)
A 3D microscope image of healthy micro vessels in kidney tissue (specimen highlighting a glomerulus, one of millions of near identical filtering units within our kidneys). The sugars on the surface of the micro vessels and red blood cells (RBC) have both been labelled green, the underlying cell membranes have been labelled red and cell nuclei are blue.
Image Credit: University of Bristol
Scientific Frontline: Extended "At a Glance" Summary: Endothelial-Erythrocyte Glycocalyx Exchange
The Core Concept: A novel diagnostic method that detects the earliest stages of heart and kidney disease by tracking microscopic changes to the glycocalyx, the protective lining of tiny blood vessels.
Key Distinction/Mechanism: Instead of relying on invasive tissue biopsies or advanced microscopy, this method identifies microscopic vascular damage by analyzing a biochemical "imprint." This imprint is created when the glycocalyx transfers its sugar and protein components onto circulating red blood cells as they contact the vessel walls.
Major Frameworks/Components:
- The Glycocalyx: A highly sensitive, sugar- and protein-rich barrier lining the inside of blood vessels that regulates bloodstream exchanges and directs immune cells.
- Microvasculature: The previously inaccessible vast network of tiny vessels that supply vital organs with oxygen and nutrients.
- Erythrocytes (Red Blood Cells): The circulating cells that act as carriers of the biochemical imprint after contacting the blood vessel walls.
Branch of Science: Vascular Biology, Nephrology, Cardiology, and Diagnostic Pathology.
Future Application: The development of routine "liquid biopsies" allowing physicians to proactively assess a patient's risk for heart and kidney diseases, monitor the ongoing health of the vascular system, and rapidly measure the effectiveness of drugs aimed at restoring the blood vessel lining.
Why It Matters: Heart and kidney conditions account for one in three deaths globally. This non-invasive method provides a crucial window of opportunity for preventative healthcare, allowing medical professionals to intervene and treat microscopic vascular damage before it becomes irreversible or life-threatening.
Scientists have discovered a new way to detect the onset of heart and kidney disease far earlier than previously possible. The breakthrough, published in Nature Communications, reveals a novel method for identifying damage to the lining of microscopic blood vessels, transforming our ability to detect disease at its earliest stages, before it progresses and becomes potentially life-threatening.
Until now, monitoring the health of the vast network of tiny blood vessels that supply vital organs with oxygen and nutrients has remained largely inaccessible. In this new study, researchers show that damage to the lining of these microscopic blood vessels signals the earliest stages of heart and kidney disease, conditions that together account for one in three deaths worldwide.
Previously, detecting this type of vascular damage relied on invasive tissue biopsies and advanced microscopy techniques. In this breakthrough, the Bristol team demonstrates a new way to identify damage to the blood vessel lining by tracking changes in the sugar- and protein-rich coating on the surface of these vessels, known as the glycocalyx.
This thin, protective layer lines the inside of blood vessels, but it is highly sensitive and can change rapidly at the earliest signs of illness. The glycocalyx also acts as a crucial barrier, regulating what moves in and out of the bloodstream and directing immune cells to where they are needed. Researchers show that when the glycocalyx becomes damaged, it serves as the earliest marker of disease.
Using advanced chemical techniques, the team demonstrated that as blood circulates throughout the body, red blood cells and blood vessel walls continuously exchange components of this protective coating when they come into contact. Importantly, they found that the transfer of the glycocalyx onto red blood cells creates a biochemical "imprint" that closely reflects the condition of the blood vessel lining.
This discovery paves the way for a simple blood test that could allow doctors to detect blood vessel damage and assess a person’s risk of developing heart- and kidney-related diseases at an earlier stage than ever before. Together, these findings offer a completely new way to detect and monitor vascular disease through routine blood testing.
Dr. Matthew Butler, the study’s first author, consultant senior lecturer and MRC clinician scientist at the University of Bristol, and honorary nephrology consultant at North Bristol NHS Trust (NBT), explains, “The health of our blood vessels is central to our overall health, and monitoring blood vessel damage has been a routine part of healthcare for decades. However, a huge portion of the vascular system is currently inaccessible to doctors and scientists because the vessels are too small to be seen. Our results suggest that we can use changes occurring at the surface of red blood cells to identify microscopic blood vessel damage before other markers become detectable. Most excitingly, we can also rapidly detect when drugs are effective at restoring the blood vessel lining. These findings could transform our ability to spot and treat disease before it progresses to become potentially irreversible or life-threatening.”
Simon Satchell, professor of renal and vascular medicine at the University of Bristol and the study’s last author, added, “Our findings provide a powerful tool for identifying potential health issues at a much earlier stage. This discovery could pave the way for proactive, preventive healthcare, offering the possibility of addressing diseases before they develop.”
Dr. David Crosby, chief research officer at Kidney Research UK, added, "We are delighted to hear the results of this research from Dr. Butler, Professor Satchell, and their team at the University of Bristol. Our cardiovascular health is closely linked to our kidney health. This novel method for assessing the health of our tiny, microscopic blood vessels is key to identifying damage happening in the early stages of kidney and heart disease. More research is needed, but this new method may give us a window of opportunity to detect disease and intervene early, and to save lives—we're excited to see how this progresses."
Funding: The study was directly funded by the Medical Research Council (MRC) and Kidney Research UK (KRUK). The British Heart Foundation (BHF) and Diabetes UK funded one or more of the co-authors.
Published in journal: Nature Communications
Title: Endothelial-erythrocyte glycocalyx exchange enables liquid biopsies of endothelial function
Authors: Matthew J. Butler, Raina R. Ramnath, Michael Crompton, Jasmine Aldam, Monica Gamez, Colin Down, Charley Heffer, Chris Neal, Jialu Li, Yan Qiu, Laura Carey, Laura Skinner, Stephen Cross, Yamaguchi Yu, Judit Sutak, Victoria Bills, Gavin I. Welsh, Rebecca R. Foster, and Simon C. Satchell
Source/Credit: University of Bristol
Reference Number: bio051226_01